News
Officials with the Food and Drug Administration have approved the continued sales of tobacco-flavored e-cigarettes and refill ...
Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...
The U.S. government is nixing a whole slew of "obsolete" U.S. food standards that Trump administration officials say also ...
The U.S. Food and Drug Administration approved a new blue color additive derived from the fruit of the gardenia, a flowering ...
Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s ...
The team spent 14 months investigating and found that the FDA had allowed more than 150 potentially unsafe drugs in the U.S.
The U.S. Food and Drug Administration has announced a plan to revoke 52 food standards after concluding they are "obsolete ...
WASHINGTON — The US Food and Drug Administration aims to revoke 52 standards of identity (SOI) across a swath of food ...
The pharmaceutical company said it remained confident in the benefit and risk profile of Blenrep and will continue to work ...
More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.
2d
EatingWell on MSNThe FDA Just Approved a New Food Dye, but What Makes It Different?The FDA just approved Gardenia (genipin) blue, a natural food dye, for certain foods and drinks. They’re also trying to ...
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results